Formulary Search
A to Z of Drugs : C
Records returned : 249 (on 29 May 2025 at 00:51:00).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
RSFT only - NHSE commissioned.
Dose is brand-specific. Check BNF for details.
Emergency treatment can be provided by RSFT, ASPH and SASH
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Prevention / prophylaxis is commissioned by NHSE. RSFT are the only Surrey Trust to which this applies.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Initiation and supply of at least one month of treatment before transfer of prescribing to primary care. Monitoring remains the responsibility of secondary care in line with position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. https://pubmed.ncbi.nlm.nih.gov/30818417/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not a 1st-line treatment option.
On-going toxicity monitoring required
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Treatment should be provided as part of obstetric care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Neonatal team only.
State dose in terms of caffeine citrate to avoid risk of dosing errors.
Caffeine citrate 2 mg = caffeine base 1 mg.
Ampoules for intravenous infusion or oral administration.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Neonatal team only.
Bioavailability of the oral solution is almost 100%.
State dose in terms of caffeine citrate to avoid risk of dosing errors.
Caffeine citrate 2 mg = caffeine base 1 mg
Ampoules for intravenous infusion or oral administration.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Used in
- hypercalcaemia of malignancy
- bone metastases
- prevention of skeletal events
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
To be used secondary to pemgatinib
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Empagliflozin is the preferred SGLT2.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centre only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Preferred angiotensin II receptor blocker.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Preferred angiotensin II receptor blocker
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Off-label use
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Specialist centres only (including ongoing supply)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oromucosal spray
Restrictions / Comments:
Important
For spasticity in MS. Specialist to prescribe for the first 12 weeks and determine response before transfer of care.
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Specilaist initiation only.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology or Respiratory Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
0.025% cream (Zacin brand) is licensed for this indication.
(0.075% Axsain cream is NOT licensed for osteoarthritis)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
For patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine)
0.075% cream (Axsain brand) is licensed for this indication
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
For patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine)
To be initiated by specialist pain care teams only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Paediatric useÂ
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not 1st line
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Paediatric use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
- Oral suspension
- Suppositories
- Tablets
Restrictions / Comments:
Important
Ensure that the patient is maintained on a specific manufacturer’s product
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Do not use in patients with active peptic ulcer disease or risk of GI bleeding.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (oral solution)
Restrictions / Comments:
Important
Reserve for patients with swallowing difficulties (aged 15 years and over)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Reserve for use in children below the age of 15 years.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye gel
Restrictions / Comments:
Important
Mild / moderate dry eye.
Prescribe by brand (primary care)
1st line: Aacomer 0.2% eye gel or Aacarb Carbomer 0.2% eye gel
2nd line: Clinitas carbomer 0.2% eye gel or Lumecare carbomer 0.2% eye gel
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
Mild / moderate dry eye.
Prescribe by brand (primary care)
1st line = Evolve Carbomer 980 prefervative free 0.2% eye gel
2nd line = Xailin 0.2% eye gel
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
Restrictions / Comments:
Important
Mild / moderate dry eye.
Prescribe by brand (primary care)
Prescribe as Ocu-Lube Carbomer 0.2%
Reserved for occasional use where unit dose is required (e.g. to carry in a bag)
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Mild / moderate dry eye.
Prescribe by brand (primary care)
1st line = AaqEye carmellose 0.5%
2nd line = Lumecare Advance Carmellose 0.5%
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
Mild / moderate dry eye.
Prescribe by brand (primary care)
1st line = Eyeaze Carmellose 0.5% PF or VIZcellose 0.5% PF
2nd line = Carmellose 0.5% PF or Ocu-Lube
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
Restrictions / Comments:
Important
Mild / moderate dry eye.
Prescribe by brand (primary care)
Prescribe as Lumecare Singles Carmellose.
Reserved for occasional use where unit dose is required (e.g. to carry in a bag)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
Mild / moderate dry eye.
Prescribe by brand (primary care)
For biometry procedure, pre-operative use in cataract surgery.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Not recommended under NICE TA878
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Modified release tablets
- Oral suspension
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialisit microbiology  recommendation.   Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available.  Use in primary care when indicated by microbiolgy eg on culture results,
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. F Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intraocular irrigation
Restrictions / Comments:
Important
Ophthalmology specialists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available. Primary care use restricted to IM injection to treat gonorrhoea.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free)
Restrictions / Comments:
Important
Restricted for Ophthalmology Specialists only in line with Microbiology recommendation.
5% eye drops / preservative free eye drops. Unlicensed.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intraocular irrigation
Restrictions / Comments:
Important
Ophthalmology specialists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Preferred COX II inhibitor for licensed indications
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not for initiation in new patients. Existing patients may remain on therapy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
For initiation by tertiary centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Severe disease only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
May be given as prophylaxis or once patient is stable after an allergic reaction
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Prescribe generically.
Available to buy over the counter.
Exceptions may apply see Guidelines on PAD
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Loratadine 5mg/5ml sugar free oral solution (from 2 years) is the 1st-line option. Cetirizine liquid is considerably more expensive and is a 2nd line option for patients unable to swallow tablets.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Specialist Centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist Centres only
Formulary Status :
Links :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye ointment
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
Reserve for patients in whom a preservative free drop is necessary
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialisit microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Dental gel
- Mouthwash
Restrictions / Comments:
Important
Available to purchase for self care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal cream
Restrictions / Comments:
Important
Preferred
Off-label use - as per CKS epistaxis guidance
0.1% or 0.5% nasal cream.
May contain Arachis oil. To check formulation prior to use in patients with a history of peanut allergy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal cream
Restrictions / Comments:
Important
0.1% or 0.5% nasal cream.
May contain Arachis oil. To check formulation prior to use in patients with a history of peanut allergy.
Not for routine use in primary care. Follow advice in CKS
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Important
Contains arachis (peanut) oil
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oral suspension
Restrictions / Comments:
Important
Unlicensed use.
Initiation and stabilisation by specialist team before transfer of prescribing to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Restricted to paediatrics - on specialist team recommendation. Unlicensed
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oral suspension
Restrictions / Comments:
Important
Paediatric use. Unlicensed.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
May be given as prophylaxis or once patient is stable after an allergic reaction
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Prescribe generically.
Available to purchase over the counter .
Exceptions may apply see Guidelines on PAD
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Transfer to primary care only once stabilised and efficacy is established.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
1st line treatment option.
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
An option for patients with swallowing difficulties.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oromucosal gel
Restrictions / Comments:
Important
Available to purchase for self care
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Off-label use. Specialist prescribing only. Endocrine testing: 3 week HCG test
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Unlicensed product. Specialist prescribing only. Endocrine testing: 3 week HCG test
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
Restrictions / Comments:
Important
0.1% ciclosporin (Ikervis). For dry eye disease that has not improved despite use of tear substitutes
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
Restrictions / Comments:
Important
0.9mg/ml (0.09%) single use.
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Intravenous infusion
Restrictions / Comments:
Important
Ulcerative colitis only. Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Ulcerative colitis only. Prescribe by brand
Ulcerative colitis only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye ointment
Restrictions / Comments:
Important
0.2% eye ointment. Specialist ophthalmology use only. Unlicensed
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
For EXISTING patients only: GPs may continue to prescribe for existing post-transplant patients only. MHS England are looking to repatriate the patients in the future. GPs must not accept requests to prescribe for new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
For NEW patients: RED drug for post-transplant. Funded by NHS England. GPs should not accept any new requests to prescribe post-transplant.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Reserve for use where a PPI AND and other H2RAs are not suitable OR where a liquid preparation is required.
Check for drug interactions.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Primary care prescribing on recommendation from specialist team for Familial hypercholesterolaemia and hypertriglyceridaemia.
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Trusts to prescribe following microbiology approval only.
Primary Care prescribing on specialist recommendation only.
0.3% eye drops.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhalation
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Off-label use
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Important
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Linctus
- Linctus (paediatric)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Acne vulgaris. Not assessed for inclusion on formulary. NICE publication date to be confirmed.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Liquid
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Use in primary care when indicated by microbiology eg on culture results. Clindamycin has a high association with the development of Clostridium Difficile. Patients and carers should be advised to stop clindamycin if diarrhoea develops.Â
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Clindamycin has a high association with the development of Clostridium Difficile. Patients and carers should be advised to stop clindamycin if diarrhoea develops.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Vaginal cream
Restrictions / Comments:
Important
Refer to local antimicrobial guidelines. Oral metronidazole is as effective as topical treatment and is more cost-effective.
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Off-label use. Palliative care team only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Rapid eye movement disorder. Can be prescribed upon recommendation from a specialist
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Reserved for severe / resistant hypertension.
Initiation and stabilisation by the specialist before transfer of prescribing to GP.
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Unlicensed
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
- Pessaries
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Solution
Restrictions / Comments:
Important
1% solution - fungal infection in otitis externa
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials. Contra-indicated in Penicillin Allergy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Contra-indicated in Penicillin Allergy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Capsules (slow release)
- Dispersible tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
- Tablets (slow release)
Restrictions / Comments:
Important
Can be prescribed upon recommendation from a specialist
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intestinal gel
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Fixed combinations are less preferable.
Low dose (8/500 co-codamol) not recommended.
Secondary Care - for A&E / discharge only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Capsules are more costly than tablets in primary care.
Fixed combinations are less preferable.
Low dose (8/500 co-codamol) not recommended.
Links :
Indication :
Status :
Formulations :
- Effervescent tablets
Restrictions / Comments:
Important
Fixed combinations are less preferable.
Low dose (8/500 co-codamol) not recommended.
Avoid effervescent formulations (high sodium content and more costly). Reserve for swallowing difficulties or patients with feeding tubes.
Secondary Care - for A&E / discharge only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Fixed combinations are less preferred. RSCH - prescribe as separate components - combination is non-formulary at RSCH.
The MHRA advises when prescribing dihydrocodeine with paracetamol, the tablet strength and dose must be clearly indicated
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Fixed combinations are less preferred.
The MHRA advises when prescribing dihydrocodeine with paracetamol, the tablet strength and dose must be clearly indicated
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Fixed combinations are less preferred.
The MHRA advises when prescribing dihydrocodeine with paracetamol, the tablet strength and dose must be clearly indicated
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
No longer licensed because of safety concerns, particularly toxicity in overdose.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist Approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Linctus
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Tablets can be dispersed for patients with swallowing difficulties.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Tablets can be dispersed for patients with swallowing difficulties.
Codeine phosphate oral solution available as 25mg/5ml.
Note 15mg/5ml linctus is only licensed for cough.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Tablets can be dissolved in water (off-label)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Codeine phosphate oral solution 25mg/5ml.
Codeine linctus 15mg/5ml is ONLY licensed for cough.
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Acute gout
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
1,000iu tablets
50,000iu capsules
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
4,000iu tablets reserved for patients unable to comply with weekly dosing
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
50,000iu/ml oral solution in ampoules - reserved for patients unable to swallow tablets / capsules
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral drops
Restrictions / Comments:
Important
10,000iu/ml oral drops sugar free - reserved for patients unable to swallow tablets / capsules
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
25,000iu tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2nd line. Colestyramine sachets (ordinary sachets, with sugar) are the preferred treatment option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Hypercholesterolaemia. Primary care prescribing on specialist team recommendation.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
ONLY for those with gastroenterology referral due to undiagnosed diarrhoea post-op.
2nd line. Colestyramine sachets (ordinary sachets, with sugar) are the preferred treatment option.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
DISCONTINUED
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Important
Preferred
These are the recommended 1st line treatment option (ordinary sachets, with sugar)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (SUGAR FREE powder)
Restrictions / Comments:
Important
3rd line colestyramine (sugar free) – for diabetic patients who request a sugar free formulation. Most costly preparation.
The ordinary powder sachets are 1st line.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Important
Diarrhoea associated with Crohn's disease, ileal resection, vagotomy, diabetic vagal neuropathy and radiation
GP may initiate on specialist recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (SUGAR FREE powder)
Restrictions / Comments:
Important
Diarrhoea associated with Crohn's disease, ileal resection, vagotomy, diabetic vagal neuropathy and radiation
GP may initiate on specialist recommendation.
Reserve the sugar-free sachets for diabetic patients on request.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Important
Hypercholesterolaemia. Primary care prescribing on specialist team recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Important
Preferred
ONLY for those with gastroenterology referral due to undiagnosed diarrhoea post-op.
This is the recommended 1st line treatment option (ordinary sachets, with sugar)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (SUGAR FREE powder)
Restrictions / Comments:
Important
ONLY for those with gastroenterology referral due to undiagnosed diarrhoea post-op AND are diabetic who request a sugar free formulation. The ordinary powder sachets are 1st line.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Important
GP may prescribe on specialist recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Powder
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialisit microbiology recommendation. Colistimethate sdoium 1million unit powder for solution for injection, infusion, inhalation vials is the most cost effective option for inhalation use by nebulisation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhalation
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
RSFT only - NHSE commissioned
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Recommend switching to a newer, lower risk formulation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Premique Low Dose - no longer recommended. Switch to a newer, lower risk formulation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Patients must be under the care of a national CHI centre (see narrative for details).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Dexcom ONE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Freestyle Libre 3
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Glucomen Day, GlucoRx Aidex, A8 Touchcare Nano.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
FreeStyle Libre 2, Freestyle Libre 2 PLUS, Dexcom ONE and Dexcom ONE PLUS - Initiation by diabetes specialist team with the first 28 days of treatment.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Freestyle Libre 3, Dexcom G7, Dexcom G6, Medtronic Guardian, Simplera Sync
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
A8 Touchcare NANO, Glucomen Day, GlucoRx Aidex
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Freestyle Libre 2 & Dexcom ONE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Preferred
PREFERRED CGM - Freestyle Libre 2 PLUS & Dexcom ONE PLUS
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Dexcom G6, Dexcom G7, GlucoRx Aidex, Medtronic Guardian, Freestyle Libre 3
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Freestyle Libre 2, Freestyle Libre 2 PLUS, Dexcom ONE & Dexcom ONE PLUS
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Freestyle Libre 3 & Dexcom G7
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
A8 Touchcare Nano, Dexcom G6, Dexcom G7, GlucoRx Aidex, Glucomen Day, Medtronic Guardian
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Enteral supplementation resistant deficiency due to malabsorption
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
On request from the specialist / Cancer Centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
1st line treatment option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
eye drops 0.5%, 1%
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
Eye drops 0.5%, 1%.
Transfer to primary care may be suitable after a minimum of 2 months supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology or Respiratory Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
In patients being supported by the One You Surrey service
Formulary Status :
Links :